This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
19, 2023 — Technologies that less invasively restore blood flow to blocked or narrowed arteries; a medicine that outsmarts high blood pressure’s development; and new evidence that diabetes drugs may offer heart health benefits to people that. DALLAS, Dec.
As we reviewed our most popular publications of 2023, it became clear that many of you continue to rethink the limits of your profession. Insights into technology and what the future holds for MRI, CT and more were among our most viewed articles by far. We’ll continue to bring you these insights and many more in 2024.
RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. Featured in an ACC.24 Featured in an ACC.24
milla1cf Wed, 12/27/2023 - 20:11 December 27, 2023 — Butterfly Network, Inc. , milla1cf Wed, 12/27/2023 - 20:11 December 27, 2023 — Butterfly Network, Inc. , Upon commercialization, the deal includes revenue share for every unit sold.
Our one-of-a-kind comparison charts allow you to do a side-by-side review of the latest technologies and products from the industry’s leading vendors. Here are links to the Top 10 viewed DAIC comparison charts from 2023: 1. The charts were created by DAIC by sending out a questionnaire to each of the vendors listed. Guidewires 2.
The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. Many technologies come and go, but this is an example of a system that has continued to advance due to the clinical value in enabling safe and reliable treatment.”
We look forward to bringing our AI technology to meet patients and physicians where they are, ultimately benefiting both worldwide.” The companies will also work together to validate the clinical utility of the integrated solution and seek regulatory clearance to bring this technology to market. Under the agreement, InfoBionic.Ai
In 2023, we continued to see advances in global health technology. These technologies provide a means to prevent, diagnose and treat cardiovascular disease and may also hold the keys to addressing health equity and improving clinician well-being.
milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , The EU MDR is arguably one of the most stringent regulatory frameworks for product approvals globally that ensures medical devices meet the rigorous standards for healthcare technologies,” said Quentin Blackford, iRhythm President and Chief Executive Officer.
If it’s been a few years since your team has opted for a new Computed Tomography (CT) scanner, you might be surprised by the progress the technology has made. Let’s look at some of the trends that have defined CT in recent years, as well as look ahead to see what the future holds for 2023 and beyond.
This study aims to analyze publications using bibliometric analysis and see the progress and identify key themes, trends, and collaboration networks.MethodData relevant to this study were obtained from Scopus and Web of Science databases from 1990 to 2023. Top countries include the USA, China, and Germany.
The meeting, held at the Queen Elizabeth II Centre, London, on 30th November and 1st December 2023, offered thought-provoking plenary sessions, focused masterclasses, a new ‘technology in action’ demonstration area, plus a number of high-quality poster presentations. Dr Aaron Henry reports highlights from the meeting.
BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. Cardiovascular diseases management is one of the areas that has benefited from using this technology. The results showed that teleconsultation via telephone and videoconferencing were the most common used technologies.
And you can't talk about innovation without technology. How Technology Fits In 2022, the consulting company Gallup asked 13,085 U.S. Investing in advanced healthcare technology can offer support on both of these fronts. Older healthcare technology has a tendency to hinder rather than help these efforts.
Record-breaking number of published papers – over 120 in 2023 alone – featuring Rapid technology and further demonstrating the superior clinical validation of the platform. While RapidAI pioneered the use of perfusion imaging in stroke, they are now pioneering the use of non-contrast CT imaging.
Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. Image courtesy: Visura Technologies, Inc. christine.book Thu, 06/13/2024 - 13:09 June 13, 2024 — Visura Technologies, Inc. , White Paper.
Abbotts new IVL IDE was two years in the making following its $890M acquisition of Cardiovascular Systems in 2023 that gave the medtech giant an entry into the IVL arena. Shockwave Medical was the first company to develop and commercialize IVL, applying it to PAD in 2016 and gaining calcified coronary artery approval in 2021.
Cardiology is an evolving field, and staying ahead with the latest technological advancements is paramount in delivering efficient, top-notch care. Embracing and implementing cutting-edge technologies allows cardiologists to provide the highest quality care and stay at the forefront of medical advancements.
(May 10, 2023) Omaha, Nebraska – Cassling, an imaging and therapeutic technology, services and solutions vendor, is launching a new team to expand its industry partnerships and make its vision a reality.
2-5, 2023, to gain perspective on the latest advances in the management of glomerular disease. Kidney Week 2023 not only served as a platform for the latest news and updates in the field but also marked the final meeting of the year for practitioners in the specialty of nephrology.
milla1cf Fri, 12/22/2023 - 08:21 December 22, 2023 — HeartBeam, Inc., HeartBeam’s core VECG technology collects 3D signals of the heart and converts them into an easy-to-interpret 12-lead ECG. To lead this effort, the company has hired Mohammad Shokoohi-Yekta, PhD, as Senior Director of Machine Learning.
In the dynamic realm of healthcare technology, cardiovascular information systems (CVIS) stand at the forefront, facilitating streamlined operations, enhanced patient care and efficient data management within cardiovascular departments.
The IVI accolade follows several major accolades for VentriJect, including winning the second-place award at the Healthcare Innovation World Cup in November 2023 from a pool of over 300 of the most innovative global healthcare start-ups. With the clinical-validated and patented technology, Seismofit, they have set out on that journey.
August 25, 2023) — Cassling, an imaging and therapeutic technology, services and solutions vendor, welcomes Brian Bradfield as Chief Operating Officer. Bradfield joins a leadership team dedicated to strengthening community healthcare across the country and touching 350 million patient lives by the end of the decade. Omaha, Neb.
Cambridge, MA-based artificial intelligence (AI)-driven health technology company, Anumana, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. Food and Drug Administration (FDA) clearance in September 2023.
1 To qualify for a Breakthrough Device Designation, a device technology must address an unmet need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly debilitating conditions. Eurointervention; 2023;18-online publish-ahead-of-print January 2023. 2,3 It has shown 99.6%
The results provide strong support for the utilization of Paragonix advanced organ preservation technologies with extended criteria donor organs,” said Dr. Andreas Zuckermann , Director for Cardiac Transplantation at the Medical University of Vienna (Austria).
with the intention of improving operations, financially supporting innovation and technology, increasing growth through additional acquisitions and ultimately, increasing profitability. Policymakers and clinicians have raised concern about the growing presence of private equity in other medical specialties.
New technologies, new workflows, new best practices. While you weren’t looking, a lot has been happening in the field of ultrasound! Over just a few short years, the potential uses of ultrasound have grown exponentially, and that means exciting things for you and your imaging team.
Magenta's technology stands at the forefront of innovation in the MCS field and has the potential to significantly improve outcomes in patients with severe cardiovascular conditions,” said Eric Snyder, Partner, Venture Investments, Novo Holdings US. Early Feasibility Study with the HR-PCI indication in 2023.
With this collaboration, HeartFocus and Butterfly will unite ground-breaking technologies, and, once deployed, empower any healthcare professional to conduct medical-grade cardiac scans from anywhere, at any time.
milla1cf Tue, 12/19/2023 - 17:05 December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration ( FDA ) clearance of the Somatom Pro.Pulse, a dual-source computed tomography scanner designed to be more affordable for a wide range of healthcare facilities, including outpatient diagnostic centers.
The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 3 “We very much appreciate FDA’s breakthrough designation recognition of the bioadaptor technology,” continued Sirhan. Food and Drug Administration (FDA). of the U.S.
2023 STS Coronary Conference Agenda gtrainyte Tue, 02/14/2023 - 09:13 Session titles and presenters are subject to change. Sabik III, MD, Cleveland, OH, USA Sigrid Sandner, MD, Vienna, Austria David Glineur, MD, PhD, Ottawa, ON, Canada Building an Advanced Coronary Surgery Program Day 1: Saturday, June 3, 2023 7:00 a.m. –
Getty Images milla1cf Tue, 12/12/2023 - 09:04 December 12, 2023 — The American Society of Echocardiography (ASE) and the ASE Foundation have awarded grant funding totaling $75,000 for three innovative cardiovascular ultrasound research projects led by early career investigators.
Implementing the 2023 Expert Consensus Statement: A Strategic Roadmap for Device Manufacturer Sales Representatives In the ever-evolving landscape of cardiac device care, keeping pace with guidelines and policies can often seem daunting.
Since its inception in 2015, Biomodex has invested over 12 million EUR in IP and R&D, leading to the development of several innovative products and technology advances which will be very synergistic to Mentice’s current portfolio.
Methods and results A systematic search of electronic databases (PubMed, EMBASE, CENTRAL) identified randomized controlled trials from January 2012 to June 2023, comparing non-invasive RPM interventions for HF with usual care. A random-effects meta-analysis assessed outcomes, and additional analyses identified effective RPM components.
In approving the TPT, CMS created a distinct device category and code (C1736: Catheter Renal Denervation, Ultrasound) for Ultrasound Renal Denervation in recognition of the differentiated technology and procedure with the Paradise uRDN System.
milla1cf Mon, 05/06/2024 - 10:50 May 6, 2024 — Teleflex Incorporate , a leading global provider of medical technologies, today announced that the Wattson Temporary Pacing Guidewire limited market release has commenced at Columbia University Irving Medical Center. Teleflex received 510(k) clearance from the U.S.
Artificial Intelligence-Augmented ECG Interpretation Using Smartphone Technology @TheEKGGuy [link] == MY Comment , by K EN G RAUER, MD ( 10/26 /2023 ): == Our THANKS to Drs. @RobertHermanMD on Making Waves from Mayo clinic.
milla1cf Tue, 04/30/2024 - 13:03 April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures. and 4.1%, respectively.
In December 2023, Ultromics proudly revealed it had been chosen to participate in the FDA's Total Product Life Cycle Advisory Program (TAP) Pilot, an exclusive cohort comprising of only 15 breakthrough cardiovascular devices.
Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.” HeartFlow remains dedicated to reshaping cardiovascular care and ensuring that hospitals have access to comprehensive, accurate, and efficient solutions in precision coronary care.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content